Bausch & Lomb generic Alphagan
Executive Summary
Bausch & Lomb receives approval May 28 for generic version of Allergan's Alphagan (brimonidine ophthalmic solution .2%); marketing exclusivity will run until Sept. 20. Allergan withdrew distribution of Alphagan .2% in August 2002 following launch of Alphagan P .15%, preserved with Purite, in 2001 (1"The Pink Sheet" March 26, 2001, In Brief). Allergan claims the .15% concentration is safer. However the firm's generic division, Pacific Pharma, plans to sell a generic version of the .2% formulation...
You may also be interested in...
Allergan Alphagan P
Brimonidine ophthalmic solution .15%, approved March 16, will be launched by fall for lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Alphagan P, preserved with Purite, has comparable efficacy to Alphagan .2%, while reducing the risk of side effects
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.